Anke Niedernberg
Corporate Officer/Principal en ADVANZ PHARMA CORP. LIMITED .
Perfil
Anke Niedernberg is currently the Chief Transformation Officer at Advanz Pharma Corp.
Ltd.
She was previously a Partner at HgCapital Beratungs GmbH & Co. KG from 2008 to 2010.
Cargos activos de Anke Niedernberg
| Empresas | Cargo | Inicio |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01/10/2021 |
Antiguos cargos conocidos de Anke Niedernberg.
| Empresas | Cargo | Fin |
|---|---|---|
| HgCapital Beratungs GmbH & Co. KG | Inversor de Capital Privado | 01/01/2010 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| HgCapital Beratungs GmbH & Co. KG | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Anke Niedernberg
